Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Ferring adds two new members to executive board

Ferring adds two new members to executive board

6th July 2017

Ferring has announced the addition of two new members to its executive board, with immediate effect.

Aaron Graff, who has been with the company since 2002, has been appointed executive vice-president and chief commercial officer of the business. Since 2010, he has led Ferring's US operations from its American headquarters in New Jersey.

Mr Graff also previously worked at Bristol-Myers Squibb for 17 years, and has been credited with driving double-digit sales for Ferring's US operations.

Meanwhile, Lars Peter Brunse has been appointed executive vice-president and chief production officer of Ferring, having originally joined the company from Novo Nordisk in 2000.

He was rapidly promoted to the role of senior vice-president for technical operations and logistics, leading the expansion of the company's manufacturing capabilities with the development of an additional nine production sites, and extending its product supply network from approximately 500 employees in 2000 to more than 1,600 today.

Michel Pettigrew, president of the executive board and chief operating officer of Ferring Pharmaceuticals, praised Mr Graff for his "broad, global professional experience and track record", while highlighting Mr Brunse's "team-focused leadership style".

With over 20 years of experience within the pharmaceutical market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current pharmaceutical roles we have available, you can search for the latest job roles, register your details, or contact the team today.ADNFCR-8000103-ID-801837625-ADNFCR

We have hundreds of jobs available across the Healthcare industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.